https://assets.capyfin.com/instruments/678fdc13234e27009c5d590b.png avatar
IQVIA
🇺🇸 NYSE:IQV
View Company
OverviewEarningsDividends
•
Sep 30, 2024

IQVIA Q3 2024 Earnings Report

IQVIA's financial performance was solid, marked by revenue growth and strong earnings per share.

Key Takeaways

IQVIA reported Q3 2024 results with revenue of $3,896 million, a GAAP Net Income of $285 million, and an adjusted EPS of $2.84. The company has updated its full-year 2024 guidance due to delays in mega trials.

Revenue reached $3,896 million.

GAAP Net Income totaled $285 million, with Adjusted EBITDA at $939 million.

GAAP Diluted Earnings per Share was $1.55, while Adjusted Diluted Earnings per Share was $2.84.

R&D Solutions contracted backlog grew to $31.1 billion, reflecting an 8.0 percent year-over-year increase.

Total Revenue
$3.9B
Previous year: $3.74B
+4.3%
EPS
$2.84
Previous year: $2.49
+14.1%
R&DS Next 12 Months Revenue
$31.1B
Previous year: $28.8B
+8.0%
Gross Profit
$1.38B
Previous year: $1.31B
+5.2%
Cash and Equivalents
$1.57B
Previous year: $1.22B
+28.4%
Free Cash Flow
$571M
Previous year: $437M
+30.7%
Total Assets
$27.2B
Previous year: $26B
+4.6%

IQVIA

IQVIA

IQVIA Revenue by Segment

Forward Guidance

Full-year 2024 guidance updated for revenue to be between $15,350 million and $15,400 million, Adjusted EBITDA between $3,675 million and $3,700 million, and Adjusted Diluted Earnings per Share between $11.10 and $11.20.

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Company Overview

Full financial data and analysis

View IQVIA